Treatment of Hypocalcemia
The treatment for hypocalcemia depends on symptom severity, with symptomatic patients requiring immediate calcium supplementation through calcium gluconate 50-100 mg/kg IV administered slowly with ECG monitoring for acute cases, while oral calcium salts such as calcium carbonate combined with vitamin D sterols are appropriate for chronic management. 1, 2, 3
Assessment of Hypocalcemia
- Hypocalcemia is defined as serum calcium levels below 8.4 mg/dL (2.10 mmol/L) 1, 4
- Clinical symptoms include paresthesia, Chvostek's and Trousseau's signs, bronchospasm, laryngospasm, tetany, and seizures 1, 5
- Verify if hypocalcemia is true or due to hypoalbuminemia using the formula: Corrected total calcium (mg/dL) = Total calcium (mg/dL) + 0.8 [4 - Serum albumin (g/dL)] 4, 6
- Low ionized calcium levels at admission are associated with increased mortality and need for massive transfusion in trauma patients 1
Acute Symptomatic Hypocalcemia Management
- For symptomatic patients, administer calcium gluconate 50-100 mg/kg IV slowly with ECG monitoring 1
- Calcium chloride injection (10%) is indicated when prompt increase in plasma calcium levels is required 2
- Calcium gluconate injection is specifically indicated for acute symptomatic hypocalcemia in both pediatric and adult patients 3
- Monitor cardiac rhythm and ECG during IV calcium administration due to risk of cardiac complications 1, 7
- Use caution if phosphate levels are high, as increased calcium might increase the risk of calcium phosphate precipitation in tissues 1
Chronic Hypocalcemia Management
- For asymptomatic patients with mild hypocalcemia, no immediate intervention is recommended 1, 7
- Treatment is indicated when:
- Oral calcium supplementation (calcium carbonate) should be used for long-term management 1
- Vitamin D supplementation should be added:
Special Considerations
- Total elemental calcium intake (dietary plus supplements) should not exceed 2,000 mg/day 1
- Monitor serum calcium and phosphorus levels every 3 months during treatment 1, 7
- Discontinue vitamin D therapy if serum corrected total calcium exceeds 10.2 mg/dL or if hyperphosphatemia persists 1
- For hypocalcemia in Williams syndrome, consider more frequent monitoring (every 4-6 months until 2 years of age, then every 2 years) 1
- Identify and address underlying causes of hypocalcemia, which may include:
Monitoring During Treatment
- For acute management, monitor calcium levels frequently until stabilized 1, 7
- For chronic management, check serum calcium and phosphorus every 3 months 1, 4
- Reassess vitamin D levels annually in patients with chronic hypocalcemia 1, 4
- Monitor for hypercalciuria in patients on long-term calcium and vitamin D supplementation 1, 7